As per our report, the size of the Single-Cell Analysis Market in Latin America was worth USD 0.23 billion in 2020 and estimated to be growing at a CAGR of 17.13% to reach USD 0.51 billion by 2025 during the forecast period.
Single-cell analysis is defined as assaying the products of or monitoring various biochemical processes and reactions in an individual cell. Further research today in the field of single-cell analysis has helped biologists to learn about gene expression profiles in cells and also reduced errors in research that would otherwise occur as a result of biologists taking averages in a heterogeneous population. Other areas of applications of single-cell analysis include drug and candidate screening, cell differentiation, measurement of stochastic stimuli, and biomarker discovery.
The high prevalence of infectious diseases mainly drives the Latin American single-cell analysis market. The rise of diseases such as HIV, HCV, and others require extensive research to find a cure, single-cell analysis helps in deriving this cure, and hence it serves as a driver for the market. The geriatric population is also more vulnerable to diseases and infections, and the applications of single-cell analysis are essential in this respect as well, as the global aging population continues to rise. As for the constraints of the market, the inflated costs of the analysis, as well as the numerous regulations put in place, citing protection of intellectual property, hamper the growth of the market.
This research report on the Latin America Single Cell Analysis Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Regionally, the Latin America single-cell analysis market is predicted to have steady growth during the forecast period owing to the increasingly large scale manufacture of proteins, cell line development, increasing biotechnology and biopharmaceutical industries of this region.
Brazilian single-cell analysis market held for the largest share in the Latin American market in 2019 had a market share of 42% in 2019. Factors such as growing healthcare expenditure, rising perforation of molecular diagnostics, and increasing patient population awareness are further expanding the market of this region. Moreover, the increase of diseases such as HCV, HIV, and other diseases need broad research to find treatment, the single-cell analysis market, and acts as a significant factor in driving the growth forward.
Mexico, Argentine are following Brazil in displaying a healthy growth rate during the forecast period.
Some of the top companies leading the Latin America single-cell analysis market profiled in the report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General Electric Company, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Cell
5.1.1 Introduction
5.1.2 Human Cells
5.1.3 Animal Cells
5.1.4 Microbial Cells
5.1.5 Y-o-Y Growth Analysis, By Cell
5.1.6 Market Attractiveness Analysis, By Cell
5.1.7 Market Share Analysis, By Cell
5.2 Products
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.4 Y-o-Y Growth Analysis, By Products
5.2.5 Market Attractiveness Analysis, By Products
5.2.6 Market Share Analysis, By Products
5.3 Techniques
5.3.1 Introduction
5.3.2 Flow Cytometry
5.3.3 NGS
5.3.4 PCR
5.3.5 Microscopy
5.3.6 Mass Spectrometry
5.3.7 Other Techniquess
5.3.8 Y-o-Y Growth Analysis, By Techniques
5.3.9 Market Attractiveness Analysis, By Techniques
5.3.10 Market Share Analysis, By Techniques
5.4 Applications
5.4.1 Introduction
5.4.2 Research Application
5.4.3 Medical Application
5.4.4 Y-o-Y Growth Analysis, By Applications
5.4.5 Market Attractiveness Analysis, By Applications
5.4.6 Market Share Analysis, By Applications
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Cell
6.1.3.3 By Products
6.1.3.4 By Techniques
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Cell
6.1.4.3 By Products
6.1.4.4 By Techniques
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Cell
6.1.5.3 By Products
6.1.5.4 By Techniques
6.1.5.5 By Application
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Danaher Corporation
8.1.1 Overview
8.1.2 Cell Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Becton
8.4 Dickinson and Company
8.5 Promega Corporation
8.6 General Electric Company
8.7 Thermo Fisher Scientific
8.8 Miltenyi Biotec
8.9 Illumina
8.10 Bio-Rad Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
